Wacker Chemie
EMEA
Munich
,
Germany
Multinational
FOUNDED
1914
HEADCOUNT
10000+
FUNDING
Public
Keywords:
CDMO, bacteria, fermentation, metabolic_engineering, amino_acids, enzymes, therapeutics, DNA_synthesis
BUSINESS
Global chemical company with divisions in silicones, polymers, and biosolutions. Provides biopharmaceutical manufacturing, fermentation-based products, and specialty chemicals.
BIOTECH INVOLVEMENT
Core in parts; operates a dedicated biotechnology division (WACKER BIOSOLUTIONS). Commercial producer of fermentation-derived L-cysteine using proprietary metabolically engineered E. coli, replacing traditional extraction from hair and feathers. Operates an 800 m³ fermentation plant in León, Spain. Also produces cyclodextrins via enzymatic starch conversion and provides CDMO services for pharmaceutical proteins via microbial fermentation. Actively developing new fermentation products and live biotherapeutic manufacturing capability
TECHNOLOGY PLATFORM
microbial fermentation; recombinant protein expression; pDNA platform
PRIMARY PRODUCTS
Recombinant proteins; plasmid DNA; cystine; biopharmaceutical CDMO services